Model‐Informed Drug Discovery and Development: Current Industry Good Practice and Regulatory Expectations and Future Perspectives

Good practices around model‐informed drug discovery and development (MID3) aim to improve the implementation, standardization, and acceptance of these approaches within drug development and regulatory review. A survey targeted to clinical pharmacology and pharmacometric colleagues across industry, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Marshall, Scott, Madabushi, Rajanikanth, Manolis, Efthymios, Krudys, Kevin, Staab, Alexander, Dykstra, Kevin, Visser, Sandra A.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389350/
https://www.ncbi.nlm.nih.gov/pubmed/30411538
http://dx.doi.org/10.1002/psp4.12372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389350/
https://www.ncbi.nlm.nih.gov/pubmed/30411538
http://dx.doi.org/10.1002/psp4.12372

Ejemplares similares